RE001 T Cell Injection for the Treatment of KRAS G12V Mutated Solid Tumors
Clinical trial NCT06545201 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06545201
- Sponsor
- Henan Cancer Hospital
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-08-01
- Primary completion
- 2026-04-01
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.